Prostate Cancer Recurrence Quiz: Test Your Knowledge
Last updated: October 2021
Prostate cancer can sometimes come back after treatment, and the fear of recurrence can be a source of anxiety for many men. We asked the community about recurrence in our 2020 In America Survey, and more than 1,100 people responded. Test your knowledge of the findings, and see what the community said about recurrence.
From diagnosis to now
From diagnosis to treatment to the ongoing fear of recurrence, prostate cancer is a physical and mental battle. Here is what respondents said about initial diagnosis, remission, and recurrence.

Community Poll
What percentage of respondents were initially diagnosed with stage 1 prostate cancer?

Community Poll
How many respondents have been in remission for 2 or more years?

Community Poll
What percentage of respondents have had at least 1 recurrence?
Getting a second opinion
It can be important to seek a second opinion when deciding on treatment options and facing recurrence. Here is what community members said about that process.

Community Poll
What percentage of respondents sought out second opinions?

Community Poll
What percentage of respondents sought second opinions after recurrence?
Ongoing PSA testing
Some men turn to the prostate-specific antigen (PSA) test to monitor whether prostate cancer may be returning. Here is what the community said about the frequency of those tests and the findings.

Community Poll
What percentage of respondents reported that they had their most recent PSA test within the last 1 to 3 months?

Community Poll
What percentage of respondents reported that their most recent PSA result was higher than that of their previous test?
Ongoing testing and screening for prostate cancer become part of life for many men. No matter where you are on your prostate cancer journey, there are others who can relate.
Tell us in the comments below: How did you do on this quiz, and what surprised you?
Recommended

Community Poll
Has prostate cancer changed your life? (Select all that apply)
Join the conversation